This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lawson, C. R Articles by MacGregor, G. A Search for Related Content PubMed PubMed Citation Articles by Lawson, C. R Articles by MacGregor, G. A Social Bookmarking                         What's this?

Review: Autosomal Dominant Polycystic Kidney Disease: Role of the Renin-Angiotensin System in Raised Blood Pressure in Progression of Renal and Cardiovascular Disease

Blood Pressure Unit, Dept of Cardiac & Vascular Sciences, St. George's, University of London, London, UK

Timothy W Doulton

Blood Pressure Unit, Dept of Cardiac & Vascular Sciences, St. George's, University of London, London, UK

Graham A MacGregor

Blood Pressure Unit, Dept of Cardiac & Vascular Sciences, St. George's, University of London, London, UK, gmacgreg{at}sgul.ac.uk

Raised blood pressure (BP) is extremely common in individuals with autosomal dominant polycystic kidney disease (ADPKD) and is almost invariably raised once they develop renal failure. The underlying mechanisms for the rise in BP in individuals with ADPKD are unclear. The progressive number and enlargement of renal cysts, causing structural damage to the kidneys and, thereby, affecting tubular function as well as causing distortion of the glomeruli and renal ischaemia, is likely to be of primary importance.There is some evidence from animal models that there may be over-activity of the intra-renal renin-angiotensin system (RAS) that could account for the rise in BP. Studies in man have shown conflicting results, but a recent more carefully controlled study using both measurements of activity and pharmacological blockade of the RAS clearly demonstrated no evidence of over-activity of the circulating RAS in ADPKD compared to matched individuals with essential hypertension. A more likely explanation for the rise in BP that occurs in ADPKD is retention of sodium and water due to tubular damage. Disappointingly, in spite of good evidence that RAS blocking drugs slow the progression of other renal, particularly glomerular, diseases, there is little evidence to suggest this is true for patients with ADPKD. Nevertheless, there is no doubt that lowering BP in ADPKD is just as important, if not more important, as in essential hypertension to prevent cardiovascular disease and strokes, with a recommended BP target of < 120/80 mmHg.

Key Words: Autosomal dominant polycystic kidney disease • Blood pressure • Renin-angiotensin system • Sodium • ACE inhibitor

Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 3, 139-145 (2006)
DOI: 10.3317/jraas.2006.023


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?